WEBULL

UK Penny Stocks With Market Caps Over £30M To Consider

Simply Wall St · 3d ago

The UK market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting the interconnectedness of global economies. Despite these broader market fluctuations, there remains an intriguing segment for investors: penny stocks. Although often considered a relic of past trading days, penny stocks continue to offer opportunities for growth when backed by solid financials and strategic potential. In this article, we explore three such stocks that stand out for their balance sheet strength and potential for significant returns.

Let's dive into some prime choices out of the screener.

Churchill China (AIM:CHH)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Churchill China plc manufactures and sells ceramic and related products for the hospitality and household markets across the UK, Europe, the US, and internationally, with a market cap of £39.32 million.

Operations: The company's revenue is primarily generated from its Ceramics segment, contributing £70.17 million, and its Materials segment, which adds £12.49 million.

Market Cap: £39.32M

Churchill China plc, with a market cap of £39.32 million, is debt-free and has a seasoned management team averaging 11 years of tenure. Despite trading at good value compared to peers and industry, the company faces challenges with declining net profit margins (currently 5.7% from last year's 8.1%) and negative earnings growth over the past year (-31.5%). Short-term assets (£45.6M) comfortably cover both short-term (£10.5M) and long-term liabilities (£8.3M). Recent auditor changes reflect a competitive tender process rather than financial distress, indicating stability in governance practices amidst an unstable dividend track record.

AIM:CHH Debt to Equity History and Analysis as at Jul 2026
AIM:CHH Debt to Equity History and Analysis as at Jul 2026

ECO Animal Health Group (AIM:EAH)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: ECO Animal Health Group plc, along with its subsidiaries, manufactures and supplies animal health products internationally, with a market cap of £59.97 million.

Operations: The company generates revenue primarily from its Pharmaceuticals segment, amounting to £87.53 million.

Market Cap: £59.97M

ECO Animal Health Group plc, with a market cap of £59.97 million, demonstrates financial stability by being debt-free and having short-term assets (£64.5M) that exceed both short-term (£18.9M) and long-term liabilities (£4.2M). The company reported earnings growth of 29.9% over the past year, although this did not surpass industry averages. Recent developments include the commercial launch of ECOVAXXIN® MS in the EU, leveraging an established distribution network to access significant poultry markets. Despite low return on equity (3.8%), ECO's improved profit margins and sustainable gross margin performance provide a positive outlook for future profitability in fiscal year 2027.

AIM:EAH Revenue & Expenses Breakdown as at Jul 2026
AIM:EAH Revenue & Expenses Breakdown as at Jul 2026

Ten Lifestyle Group (AIM:TENG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Ten Lifestyle Group Plc provides concierge services to private banks, premium financial services, and high-net-worth individuals across Europe, Asia-Pacific, the Middle East, Africa, and the Americas with a market cap of £86.68 million.

Operations: Revenue Segments: No specific revenue segments are reported for Ten Lifestyle Group Plc.

Market Cap: £86.68M

Ten Lifestyle Group Plc, with a market cap of £86.68 million, shows financial resilience by being debt-free and having short-term assets (£21.6M) that exceed both short-term (£18.9M) and long-term liabilities (£6.3M). Despite negative earnings growth last year, the company has achieved profitability over the past five years with high-quality earnings. Recent strategic developments include a partnership with Graebel Companies Inc., enhancing service offerings through Catalyst, an executive transition experience. The company's revenue guidance for fiscal 2027 suggests potential growth beyond current forecasts, supported by new contracts launching in late 2026.

AIM:TENG Debt to Equity History and Analysis as at Jul 2026
AIM:TENG Debt to Equity History and Analysis as at Jul 2026

Where To Now?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.